SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-036257
Filing Date
2015-05-08
Accepted
2015-05-08 16:15:17
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7010_110q.htm 10-Q 1002975
2 EX-31.1 a15-7010_1ex31d1.htm EX-31.1 12058
3 EX-31.2 a15-7010_1ex31d2.htm EX-31.2 12049
4 EX-32.1 a15-7010_1ex32d1.htm EX-32.1 7552
5 EX-32.2 a15-7010_1ex32d2.htm EX-32.2 7693
12 GRAPHIC g70101bai001.jpg GRAPHIC 2448
  Complete submission text file 0001104659-15-036257.txt   8113149

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abbv-20150331.xml EX-101.INS 1315234
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20150331.xsd EX-101.SCH 46044
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20150331_cal.xml EX-101.CAL 64188
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20150331_def.xml EX-101.DEF 214829
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT abbv-20150331_lab.xml EX-101.LAB 531938
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20150331_pre.xml EX-101.PRE 362350
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35565 | Film No.: 15846913
SIC: 2834 Pharmaceutical Preparations